Close Menu
The Westside GazetteThe Westside Gazette
    Facebook X (Twitter) Instagram
    • About Us
    • Contact
    • Media Kit
    • Political Rate Sheet
    • Links
      • NNPA Links
      • Archives
    • SUBMIT YOUR VIDEO
    Facebook X (Twitter) Instagram
    The Westside GazetteThe Westside Gazette
    Advertise With Us
    • Home
    • News
      • National
      • Local
      • International
      • Business
      • Releases
    • Entertainment
      • Photo Gallery
      • Arts
    • Politics
    • OP-ED
      • Opinions
      • Editorials
      • Black History
    • Lifestyle
      • Health
      • HIV/AIDS Supplements
      • Advice
      • Religion
      • Obituaries
    • Sports
      • Local
      • National Sports
    • Podcast and Livestreams
      • Just A Lil Bit
      • Two Minute Warning Series
    The Westside GazetteThe Westside Gazette
    You are at:Home » PixCell Device Produces In-Office Blood Test Results In 6 Minutes
    News

    PixCell Device Produces In-Office Blood Test Results In 6 Minutes

    January 2, 20212 Mins Read0 Views
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email
    Advertisement

    Silicon Valley-based Theranos famously promised an in-office blood analysis device that could conduct dozens of tests from a single finger prick. That claim turned out to be fraudulent. But other startups — including three from Israel — are attempting to get it right.

    One of them, PixCell Medical of Israel, was just named to PM360’s Innovative Companies of 2020 list. PM360 is a monthly magazine covering the pharmaceutical, biotech, medical device and diagnostics industries.

    A recent study conducted by the University of Maryland and Sweden’s Linköping and Uppsala Universities compared PixCell’s HemoScreen system to standard analyzers. It found HemoScreen can deliver “lab-equivalent results rapidly at the point of care.”

    Results are returned in just six minutes and require only a single drop of blood.

    Rapid diagnostics have become even more important in 2020 as a means of “managing COVID-19 patients’ disease progression and clinical decision-making,” said PixCell Medical CEO Dr. Avishay Bransky.

    PixCell uses viscoelastic focusing (VEF)technology to line up cells in a single plane for easier and faster analysis, utilizing artificial intelligence and machine learning.

    “You can differentiate between many types and subtypes of cells, and you are able to also enumerate and detect abnormal cells, which is not possible with even the highest level of full-blown analyzers,” Bransky said.

    PixCell Medical’s HemoScreen competes with two other Israeli startups in the same blood-testing space: Sight Diagnostics’ OLO point-of-care 10-minute blood diagnostics device that also only requires only a finger prick of blood (another PM360 pick); and the battery-powered RevDx blood count device from Engineering for All.

    (Stock photo by Yassine Khalfalli)

    PixCell’s HemoScreen received FDA clearance in 2018.

    The company, founded in 2009 and based in Yokne’am, Israel, counts among its clients Changing Cancer Care, an EU-backed project to treat oncology patients at home in the border region of Denmark and Germany; the Karolinska Institute and Uppsala University in Sweden; and NSW Health Pathology in New South Wales, Australia.

    To learn more about PixCell Medical’s technology, Bransky published a paper in The Journal of Applied Laboratory Medicine.

    In-office blood test results in six minutes appeared first on ISRAEL21c.

    (Edited by Fern Siegel and David Martosko)



    The post PixCell Device Produces In-Office Blood Test Results In 6 Minutes appeared first on Zenger News.

    Share. Facebook Twitter Pinterest LinkedIn Reddit WhatsApp Telegram Email
    info@zenger.news'
    zenger.news
    • Website

    Related Posts

    The Blueprint of Manipulation: How Jeffrey Epstein’s Power Network Conditioned it’s Victims

    November 17, 2025

    Donate to the National Newspaper Publishers Association

    November 4, 2025

    Target continues to challenge our spending power, so we must continue to take action • Full Target Boycott! ✊

    April 28, 2025
    Advertisement

    View Our E-Editon

    Advertisement

    –>

    Advertisement
    Advertisement
    advertisement

    Advertisement

    –>

    The Westside Gazette
    Facebook X (Twitter) Instagram Pinterest
    © 2025 The Westside Gazette - Site Designed by No Regret Media.

    Type above and press Enter to search. Press Esc to cancel.

    Go to mobile version